These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32580547)

  • 1. Dual-Modal Therapeutic Role of the Lactate Oxidase-Embedded Hierarchical Porous Zeolitic Imidazolate Framework as a Nanocatalyst for Effective Tumor Suppression.
    Zhou X; Zhao W; Wang M; Zhang S; Li Y; Hu W; Ren L; Luo S; Chen Z
    ACS Appl Mater Interfaces; 2020 Jul; 12(29):32278-32288. PubMed ID: 32580547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoscale dual-enzyme cascade metal-organic frameworks through biomimetic mineralization as ROS generators for synergistic cancer therapy.
    Jin S; Weng L; Li Z; Yang Z; Zhu L; Shi J; Tang W; Ma W; Zong H; Jiang W
    J Mater Chem B; 2020 Jun; 8(21):4620-4626. PubMed ID: 32373876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy.
    Song Y; Sun Y; Tang M; Yue Z; Ni J; Zhao J; Wang W; Sun T; Shi L; Wang L
    ACS Appl Mater Interfaces; 2022 Feb; 14(4):4914-4920. PubMed ID: 35050579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Photothermal Tumor Immunotherapy by 1-MT Based on Zeolitic Imidazolate Framework-8 with pH-High Sensitivity.
    Su R; Yang Y; Wu H; Liu B; Tian X; Zhou C; Hu Y; Liu T
    Int J Nanomedicine; 2024; 19():8501-8517. PubMed ID: 39185344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
    Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zeolitic Imidazolate Framework Platform for Combinational Starvation Therapy and Oxygen Self-Sufficient Photodynamic Therapy against a Hypoxia Tumor.
    Ouyang Y; Wang P; Huang B; Yang G; Tian J; Zhang W
    ACS Appl Bio Mater; 2021 May; 4(5):4413-4421. PubMed ID: 35006853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy.
    Ding L; Lin X; Lin Z; Wu Y; Liu X; Liu J; Wu M; Zhang X; Zeng Y
    ACS Appl Mater Interfaces; 2020 Aug; 12(33):36906-36916. PubMed ID: 32706242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-Targeted Zeolitic Imidazolate Frameworks Drug Delivery System Reversing Cisplatin Resistance to Treat Resistant Ovarian Cancer.
    Xing Y; Jing R; Tang X; Jiang Z
    Int J Nanomedicine; 2024; 19():6603-6618. PubMed ID: 38979533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine serum albumin-coated ZIF-8 nanoparticles to enhance antitumor and antimetastatic activity of methotrexate:
    Salimi M; Adibifar A; Rostamkhani N; Karami Z; Agh-Atabay AH; Abdi Z; Rostamizadeh K
    J Biomater Sci Polym Ed; 2024 Oct; 35(15):2294-2314. PubMed ID: 39037940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fe
    Xu Y; Wang S; Xiong J; Zheng P; Zhang H; Chen S; Ma Q; Shen J; Velkov T; Dai C; Jiang H
    Adv Healthc Mater; 2024 Jun; 13(14):e2303839. PubMed ID: 38334034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel catalytic micromotor of porous zeolitic imidazolate framework-67 for precise drug delivery.
    Wang L; Zhu H; Shi Y; Ge Y; Feng X; Liu R; Li Y; Ma Y; Wang L
    Nanoscale; 2018 Jun; 10(24):11384-11391. PubMed ID: 29877544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly bioactive zeolitic imidazolate framework-8-capped nanotherapeutics for efficient reversal of reperfusion-induced injury in ischemic stroke.
    He L; Huang G; Liu H; Sang C; Liu X; Chen T
    Sci Adv; 2020 Mar; 6(12):eaay9751. PubMed ID: 32206718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shielding against Unfolding by Embedding Enzymes in Metal-Organic Frameworks via a de Novo Approach.
    Liao FS; Lo WS; Hsu YS; Wu CC; Wang SC; Shieh FK; Morabito JV; Chou LY; Wu KC; Tsung CK
    J Am Chem Soc; 2017 May; 139(19):6530-6533. PubMed ID: 28460166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cascade-reaction enabled synergistic cancer starvation/ROS-mediated/chemo-therapy with an enzyme modified Fe-based MOF.
    Liu Z; Li T; Han F; Wang Y; Gan Y; Shi J; Wang T; Akhtar ML; Li Y
    Biomater Sci; 2019 Aug; 7(9):3683-3692. PubMed ID: 31361291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment-responsive polydopamine-based core/shell nanoplatform for synergetic theranostics.
    Chen Q; Shan X; Shi S; Jiang C; Li T; Wei S; Zhang X; Sun G; Liu J
    J Mater Chem B; 2020 May; 8(18):4056-4066. PubMed ID: 32270145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZIF-Based Nanoparticles Combine X-Ray-Induced Nitrosative Stress with Autophagy Management for Hypoxic Prostate Cancer Therapy.
    Li Y; Gong T; Gao H; Chen Y; Li H; Zhao P; Jiang Y; Wang K; Wu Y; Zheng X; Bu W
    Angew Chem Int Ed Engl; 2021 Jul; 60(28):15472-15481. PubMed ID: 33964189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocatalytic Tumor Therapy by Single-Atom Catalysts.
    Huo M; Wang L; Wang Y; Chen Y; Shi J
    ACS Nano; 2019 Feb; 13(2):2643-2653. PubMed ID: 30753056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile construction of gefitinib-loaded zeolitic imidazolate framework nanocomposites for the treatment of different lung cancer cells.
    Aiyasamy K; Ramasamy M; Hirad AH; Arulselvan P; Jaganathan R; Suriyaprakash J; Thangavelu I; Alarfaj AA
    Biotechnol Appl Biochem; 2024 Aug; 71(4):896-908. PubMed ID: 38594878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Roles of Metal-Organic Frameworks as Nanocarriers for miRNA Delivery and Adjuvants for Chemodynamic Therapy.
    Zhao H; Li T; Yao C; Gu Z; Liu C; Li J; Yang D
    ACS Appl Mater Interfaces; 2021 Feb; 13(5):6034-6042. PubMed ID: 33499584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MOF nanoparticles with encapsulated dihydroartemisinin as a controlled drug delivery system for enhanced cancer therapy and mechanism analysis.
    Li Y; Song Y; Zhang W; Xu J; Hou J; Feng X; Zhu W
    J Mater Chem B; 2020 Aug; 8(33):7382-7389. PubMed ID: 32648887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.